HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
about
ZNF703 gene amplification at 8p12 specifies luminal B breast cancerOncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsDietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC InhibitionSustained proliferation in cancer: Mechanisms and novel therapeutic targetsCooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesisCancer stem cells and their mechanism of chemo-radiation resistancePathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer.Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer.Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.Single compartment drug delivery.Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.Determining duration of HER2-targeted therapy using stem cell extinction models.Role of Notch and its oncogenic signaling crosstalk in breast cancer.Evaluation of anticancer agents using flow cytometry analysis of cancer stem cellsThe emerging importance of α-L-fucose in human breast cancer: a review.A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumorsHER2 and breast cancer stem cells: more than meets the eye.Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial.Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.A novel Monoclonal Antibody against Notch1 Targets Leukemia-associated Mutant Notch1 and Depletes Therapy Resistant Cancer Stem Cells in Solid Tumors.A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.Cancer stem cells: potential target for bioactive food componentsPhysical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src ActivationArsenic trioxide inhibits cell growth and induces apoptosis through inactivation of notch signaling pathway in breast cancer.Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κBCancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.The cancer stem cell paradigm: a new understanding of tumor development and treatment.Finally! A model for progesterone receptor action in normal human breastLeptin-cytokine crosstalk in breast cancer.Asymptomatic changes in cardiac function can occur in ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines.Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.HER2 expression identifies dynamic functional states within circulating breast cancer cells.Adjuvant therapy of triple negative breast cancer.
P2860
Q24293333-73E2F441-A529-452E-89FA-5D923213225EQ26861403-9FCE64B5-54C3-412B-818B-A55CFEAEC51BQ27026986-B776147B-971C-4663-99FC-5C74A5A820A3Q28396388-839CF9BE-CE4E-4140-A65A-48CCF894B6CFQ33601436-E2B76890-E93E-486C-A547-345F16CEEDFCQ33614696-FD8E4DBB-7CC1-4108-B6DA-8FC2FEAB07C3Q33737058-104BCA20-2145-4938-98A4-BE97C758F57DQ33745632-209D1302-78C3-4229-805F-146D9F8897EBQ33818946-C5B5BB85-3C31-4BBE-A6BE-70A7DA07EA5DQ34038793-296B8AA7-0D4A-4AAB-B8CD-861F462B6920Q34103963-22B35D91-BBB0-4116-B753-BA260135D48CQ34131280-8BF1E0AC-8612-49A0-9141-2C00AD7A7BC7Q34194672-BE48884D-CE69-41EF-9C13-5C1A02E7906DQ34263907-5BF95ACB-E7ED-4B57-A863-3EBFE900489AQ34270803-53DE4F4A-30F8-4C74-975F-A3E928537876Q34531367-06962895-D8A3-4C3E-B6B4-7D94ADE979F4Q34697373-5BBC65FA-44F6-491F-B3D5-3B1383D2122AQ35088739-43E9BCFB-ACFF-43E9-A074-C20EFA2D1D8AQ35172546-1D0ADF78-C333-443C-80B1-455E1F108E55Q35176075-7A5EEAE0-E912-4584-ADDE-23C71512207DQ35320325-5863E51E-FA1A-4274-8504-2A5AE109A911Q35612933-08F9B28C-B1D5-45D1-B41D-EBFA445322CFQ35686250-C8E9CE1F-AFE5-46D3-AFF2-136FE68019EDQ35687072-DEDB1E48-8E62-418D-9ED3-0EC293F7BB0DQ35750639-A838E7D6-A946-42D6-835D-70568F1CA367Q35898800-ADD36004-753A-4C67-9475-CD4835396182Q36034029-8A775507-5D2C-4202-8AA2-D1B442E19D35Q36202278-B0161B73-5EAD-4C24-BBDC-27D16362B557Q36347787-49F48B5C-E6EA-4D00-99B5-6FFF32023FEFQ36528524-DFC4B556-C80B-4C00-8813-49E128A078C2Q36544839-DE1D75A9-DAE6-4690-B2EE-4224040E2362Q36693285-13490B84-E3B7-459A-AAD4-80808CFA724EQ36782369-B1402C60-F522-49B0-A997-94EC4ECF0934Q36854372-02B70B71-32E1-4A4D-8C9E-CE27EB75D35DQ37244577-7CB7C429-E955-4A54-94C1-2B560B1AB3DCQ37351155-9FA32B39-4726-42C5-A112-B84FE645C958Q37379081-FADE594C-4AC3-4903-8CD6-0F7F76B9855EQ37470093-14664DC2-E593-43A0-B510-67E665CCAF64Q37510512-D569D169-CD42-4632-9B3A-A93EE646523FQ37571648-2BC97CB5-B005-475B-BFAE-5F65F04ACF7B
P2860
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@en
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@nl
type
label
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@en
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@nl
prefLabel
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@en
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@nl
P1476
HER-2, notch, and breast cancer stem cells: targeting an axis of evil.
@en
P2093
Hasan Korkaya
Max S Wicha
P304
P356
10.1158/1078-0432.CCR-08-3087
P407
P577
2009-03-10T00:00:00Z